RxSight Inc. Common Stock (RXST)
Stock · NASDAQ · Health Care
$7.05as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$4.85
Industry
Ophthalmic Goods
Fundamentals
- Market cap
- $251.69M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How RxSight Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 25, 2026 · via SEC EDGAR / Finnhub
RxSight Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- RXSTRxSight Inc. Common Stock$7.05▲ 6.66%Market cap $251.69MP/E —
- LUCYInnovative Eyewear Inc. Common Stock$0.97▲ 3.08%Market cap $6.19MP/E —$0.65$2.24
- LUCYWInnovative Eyewear Inc. Series A Warrants 8/16/27$0.035▼ 16.86%Market cap $556.8KP/E —$0.0251$0.181
- STAASTAAR Surgical Company Common Stock$22.1▼ 1.30%Market cap $1.15BP/E 327.25$15.59$35.87
- EYENational Vision Holdings Inc. Common Stock$17.37▼ 2.80%Market cap $1.80BP/E 34.05$14.75$30.02
- WRBYWarby Parker Inc. Class A Common Stock$25▼ 1.07%Market cap $3.31BP/E 401.34$14.96$31
- BLCOBausch + Lomb Corporation Common Shares$17.15▲ 0.12%Market cap $5.84BP/E —$13.77$18.92
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| RXST RxSight Inc. Common Stock | $251.69M | — | $7.05 | ▲ 6.66% | |
| LUCY Innovative Eyewear Inc. Common Stock | $6.19M | — | $0.97 | ▲ 3.08% | $0.65$2.24 |
| LUCYW Innovative Eyewear Inc. Series A Warrants 8/16/27 | $556.8K | — | $0.035 | ▼ 16.86% | $0.0251$0.181 |
| STAA STAAR Surgical Company Common Stock | $1.15B | 327.25 | $22.1 | ▼ 1.30% | $15.59$35.87 |
| EYE National Vision Holdings Inc. Common Stock | $1.80B | 34.05 | $17.37 | ▼ 2.80% | $14.75$30.02 |
| WRBY Warby Parker Inc. Class A Common Stock | $3.31B | 401.34 | $25 | ▼ 1.07% | $14.96$31 |
| BLCO Bausch + Lomb Corporation Common Shares | $5.84B | — | $17.15 | ▲ 0.12% | $13.77$18.92 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?Yahoo · 8/13/2026
- RxSight (RXST) Q2 2026 Earnings Call TranscriptYahoo · 8/12/2026
- Stifel Maintains Hold on RxSight, Lowers Price Target to $7Benzinga · 8/10/2026
- UBS Maintains Neutral on RxSight, Raises Price Target to $6.3Benzinga · 8/6/2026
- RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ...Yahoo · 8/6/2026
- RxSight Q2 Earnings Call HighlightsYahoo · 8/6/2026
- RxSight, Inc. (RXST) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/6/2026
- RxSight (NASDAQ:RXST) Slips After Q2 Revenue Matches, Loss NarrowsChartMill · 8/5/2026
Insider Activity
Insider Actions →Acquired
3.22M
Disposed
0
- Aziz Mottiwala · July 24, 2026 · Grant571.3K
- Aziz Mottiwala · July 24, 2026 · Grant2.31M
- Robert Keith Warner · June 17, 2026 · Grant37.0K
- Robert J. Palmisano · June 17, 2026 · Grant37.0K
- Shweta Maniar · June 17, 2026 · Grant37.0K
- Tamara Fountain · June 17, 2026 · Grant37.0K
- William J. Link, PhD · June 17, 2026 · Grant37.0K
- Jesse Anderson Corley · June 17, 2026 · Grant37.0K
- Raymond W. Cohen · June 17, 2026 · Grant30.9K
- Bakker Juliet Tammenoms · June 17, 2026 · Grant37.0K
- Julie Andrews · June 17, 2026 · Grant37.0K
- Ilya Goldshleger · April 17, 2026 · Option Exercise12.5K @ $4.13
Institutional Ownership
March 31, 2026
- Total shares held
- 37.07M
- Total value held
- $219.79M
- Institutional holders
- 158
Top holders this quarter
- Unknown3.19M
- Unknown2.06M
- Unknown2.06M
- Unknown2.00M
- Unknown2.00M
- Unknown1.96M
- Unknown1.69M
- Unknown1.30M
- Unknown1.21M
- Unknown1.17M
See the full, filterable feed with live charts on the MarketWall dashboard.